Literature DB >> 31648941

HTLV-1: the silent impact revealed.

Lucy B M Cook1, Graham P Taylor2.   

Abstract

Entities:  

Year:  2019        PMID： 31648941     DOI： 10.1016/S1473-3099(19)30432-3

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN： 1473-3099            Impact factor:   25.071


× No keyword cloud information.
  5 in total

1.  A Qualitative Study Exploring Perceptions to the Human T Cell Leukaemia Virus Type 1 in Central Australia: Barriers to Preventing Transmission in a Remote Aboriginal Population.

Authors:  Fiona Fowler; Lloyd Einsiedel
Journal:  Front Med (Lausanne)       Date:  2022-04-29

Review 2.  Antiretroviral Therapy in HTLV-1 Infection: An Updated Overview.

Authors:  Francesca Marino-Merlo; Emanuela Balestrieri; Claudia Matteucci; Antonio Mastino; Sandro Grelli; Beatrice Macchi
Journal:  Pathogens       Date:  2020-05-01

3.  Seroprevalence of human T-lymphotropic virus infection among blood donors in China: a first nationwide survey.

Authors:  Le Chang; Shanhai Ou; Zhengang Shan; Faming Zhu; Huimin Ji; Xia Rong; Fei Guo; Xinyi Jiang; Huizhen Sun; Ying Yan; Lunan Wang
Journal:  Retrovirology       Date:  2021-01-07       Impact factor: 4.602

Review 4.  Epidemiology of HTLV-1 Infection and ATL in Japan: An Update.

Authors:  Masako Iwanaga
Journal:  Front Microbiol       Date:  2020-05-29       Impact factor: 5.640

5.  Work-Related Human T-lymphotropic Virus 1 and 2 (HTLV-1/2) Infection: A Systematic Review.

Authors:  Angela Stufano; Hamid Reza Jahantigh; Francesco Cagnazzo; Francesca Centrone; Daniela Loconsole; Maria Chironna; Piero Lovreglio
Journal:  Viruses       Date:  2021-09-02       Impact factor: 5.048
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.